Lymphoma, B-cell
Showing 9976 - 10000 of >10,000
Healthy, Type 2 Diabetes Trial in Neuss, Mainz (LY3457263, Dulaglutide, Placebo)
Completed
- Healthy
- Type 2 Diabetes
- LY3457263
- +2 more
-
Neuss, Nordrhein-Westfalen, Germany
- +1 more
Jan 10, 2022
Sickle Cell Disease, Acute Chest Syndrome Trial (Tocilizumab)
Not yet recruiting
- Sickle Cell Disease
- Acute Chest Syndrome
- (no location specified)
Nov 28, 2022
Autoimmune Diseases, Premature Ovarian Insufficiency Trial in Stockholm (Rituximab)
Recruiting
- Autoimmune Diseases
- Premature Ovarian Insufficiency
-
Stockholm, SwedenAngelica Hirshberg
Oct 20, 2022
ALK-positive NSCLC Trial in Shanghai (Alkotinib Capsules)
Recruiting
- ALK-positive Non-small Cell Lung Cancer
- Alkotinib Capsules
-
Shanghai, Shanghai, ChinaShanghai Pulmonary Hospital
Nov 28, 2022
Digestive System Diseases, Inflammatory Bowel Disease, Ulcerative Colitis Type, Crohn Disease Trial in Rennes (additional
Recruiting
- Digestive System Diseases
- +2 more
- additional biopsies
-
Rennes, FranceCHU de RENNES-Service des Maladies de l'Appareil Digestif
Sep 12, 2022
Acute Myeloid Leukemia Trial in Singapore, United States (Cytarabine, Daunorubicin, Etoposide)
Advanced Stage NSCLC Trial in Amsterdam ([18F]F-AraG PET scan)
Recruiting
- Advanced Stage Non-small Cell Lung Cancer
- [18F]F-AraG PET scan
-
Amsterdam, NetherlandsAmsterdam UMC, location VU University Medical Center
Jan 17, 2023
Lymphoma, Non-Hodgkin, HIV Trial in United States (Bleomycin sulfate, Vincristine sulfate, Doxorubicin HCl)
Completed
- Lymphoma, Non-Hodgkin
- HIV Infections
- Bleomycin sulfate
- +9 more
-
Los Angeles, California
- +13 more
Oct 27, 2021
Age-Related Macular Degeneration Trial in Worldwide (SB11 (Proposed ranibizumab biosimilar), Lucentis (ranibizumab))
Completed
- Age-Related Macular Degeneration
- SB11 (Proposed ranibizumab biosimilar)
- Lucentis (ranibizumab)
-
Poway, California
- +74 more
Apr 29, 2021
Steroid Refractory GVHD Trial in Taoyuan (Ruxolitinib)
Completed
- Steroid Refractory GVHD
-
Taoyuan, TaiwanChang Gung Memorial Hospital
Dec 15, 2022
Relapsed/Refractory Acute Myeloid Leukemia (AML) Trial in Dresden, Heidelberg (Donor-derived CD34+ HSC with CRISPR/Cas9-mediated
Not yet recruiting
- Relapsed/Refractory Acute Myeloid Leukemia (AML)
- Donor-derived CD34+ HSC with CRISPR/Cas9-mediated CD33 deletion
- Gemtuzumab Ozogamicin
-
Dresden, Germany
- +1 more
Dec 20, 2022
Multiple Myeloma Trial in Houston (Belantamab mafodotin)
Recruiting
- Multiple Myeloma
- Belantamab mafodotin
-
Houston, TexasM D Anderson Cancer Center
Jan 5, 2023
Immune Checkpoint Inhibitors in Non-Small Cell Lung Carcinoma
Active, not recruiting
- Non Small Cell Lung Cancer
- Immune signature in serum associated to the metabolic signature
- Meta-genomic signature of intestinal flora
-
La Tronche, Isère, FranceUniversity Hospital, Grenoble
Jan 6, 2023
GI Motility Disorder Trial in Leuven (Corticotropin-release hormone)
Recruiting
- GI Motility Disorder
- Corticotropin-release hormone
-
Leuven, BelgiumI-Hsuan Huang
Oct 7, 2021
Liver Cirrhosis Trial in Hanoi (Human umbilical cord-derived mesenchymal stem cell infusion)
Recruiting
- Liver Cirrhosis
- Human umbilical cord-derived mesenchymal stem cell infusion
-
Hanoi, VietnamVinmec Research Institute of Stem Cell and Gene Technology
Apr 14, 2022
Cardiovascular Diseases, Endothelial Dysfunction Trial in London (COVID-19 vaccine, Concentrate beetroot Juice, Nitrate-deplete
Recruiting
- Cardiovascular Diseases
- Endothelial Dysfunction
- COVID-19 vaccine
- +2 more
-
London, United KingdomThe William Harvey Research Institute
Jan 20, 2022
Obesity Trial in Lexington (Milk Thistle (MT), Lactobacillus Gasseri (LAC), Exercise (EX))
Recruiting
- Obesity
- Milk Thistle (MT)
- +3 more
-
Lexington, KentuckyUniversity of Kentucky- Nutrition Assessment Lab
Jan 11, 2022
Aging Trial in Bangkok (Epidermal Growth Factor)
Active, not recruiting
- Aging
- Epidermal Growth Factor
-
Bangkok, ThailandInstitute of Dermatology
Feb 9, 2023
Head Neck Cancer Trial in Chengdu, Tianjin (Tislelizumab, Pulse radiation)
Recruiting
- Head and Neck Cancer
- Tislelizumab
- Pulse radiation
-
Chengdu, Sichuan, China
- +1 more
Oct 25, 2022
Type 2 Diabetes Trial in Amsterdam (Semaglutide, 2.0 mg/mL)
Not yet recruiting
- Type 2 Diabetes
- Semaglutide, 2.0 mg/mL
-
Amsterdam, Noord-Holland, NetherlandsAMC
Oct 26, 2022
Health and Fitness App Uptake and Subscription in General
Not yet recruiting
- Physical Inactivity
- +2 more
- (no location specified)
Aug 28, 2023
Neovascular Age-related Macular Degeneration
Completed
- Age-related Macular Degeneration (AMD)
-
East Hanover, New JerseyNovartis Investigative Site
Dec 15, 2021
Improved Methods of Cell Selection for Bone Marrow Transplant
Recruiting
- Graft-Versus-Host Disease
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Hemolytic Disease of the Fetus and Newborn Trial in Worldwide (Nipocalimab, Placebo)
Not yet recruiting
- Hemolytic Disease of the Fetus and Newborn
- Nipocalimab
- Placebo
-
New Haven, Connecticut
- +12 more
Jun 13, 2023